John Arrowsmith
- Molecular Biology top 5%
- Computational Theory and Mathematics top 0.5%
- Oncology top 10%
- Biomedical Engineering top 10%
- Pharmacology top 1%
- Co-authors
- J. Philip MillerAlex. M. WeirGarry PairaudeauStephen D. PickettRobert M. OwenOwen B. WallaceJi‐Bo WangPaul D. Leeson
- Topics
- Synthesis of heterocyclic compounds (3 papers)Computational Drug Discovery Methods (3 papers)Pharmaceutical Economics and Policy (3 papers)
- Journals
- Nature Reviews Drug DiscoveryJournal of Medicinal ChemistryJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- United KingdomUnited States
In The Last Decade
John Arrowsmith
19 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Molecular Biology 1.3k
- Computational Theory and Mathematics 835
- Oncology 397
- Biomedical Engineering 383
- Pharmacology 381
Countries citing papers authored by John Arrowsmith
This map shows the geographic impact of John Arrowsmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Arrowsmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Arrowsmith more than expected).
Fields of papers citing papers by John Arrowsmith
This network shows the impact of papers produced by John Arrowsmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Arrowsmith. The network helps show where John Arrowsmith may publish in the future.
Co-authorship network of co-authors of John Arrowsmith
This figure shows the co-authorship network connecting the top 25 collaborators of John Arrowsmith. A scholar is included among the top collaborators of John Arrowsmith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Arrowsmith. John Arrowsmith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | An analysis of the attrition of drug candidates from four major pharmaceutical companiesbreakdown → | 955 |
| 2 | A comprehensive analysis of development attrition in drug candidates from four major pharmaceutical companies | 1 |
| 3 | Phase II and Phase III attrition rates 2011–2012breakdown → | 450 |
| 4 | 117 | |
| 5 | 93 | |
| 6 | Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survivalbreakdown → | 463 |
| 7 | Phase III and submission failures: 2007–2010breakdown → | 317 |
| 8 | Phase II failures: 2008–2010breakdown → | 429 |
| 9 | 25 | |
| 10 | 44 | |
| 11 | 165 | |
| 12 | 16 | |
| 13 | 194 | |
| 14 | 9 | |
| 15 | 3 | |
| 16 | 4 | |
| 17 | 3 | |
| 18 | 12 | |
| 19 | 25 |
About John Arrowsmith
John Arrowsmith is a scholar working on Organic Chemistry, Virology and Computational Theory and Mathematics, having authored 19 papers that have together received 3.3k indexed citations. Recurring topics across this work include Synthesis of heterocyclic compounds (3 papers), Computational Drug Discovery Methods (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Computational Theory and Mathematics (835 citations), Pharmacology (381 citations) and Statistics and Probability (160 citations). John Arrowsmith has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include J. Philip Miller, Alex. M. Weir, Garry Pairaudeau, Stephen D. Pickett, Robert M. Owen, Owen B. Wallace, Ji‐Bo Wang, Paul D. Leeson, Andrew R. Leach and William D. Pennie. Their work appears in journals such as Nature Reviews Drug Discovery, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.